1. In relation to the diagnosis of her cerebrovascular disease at the hospital B on May 28, 2014, the Plaintiff’s Defendant.

1. Facts of recognition;

A. (1) The Plaintiff, a corporation established for the purpose of insurance business, etc., concluded an insurance contract with A on September 15, 2006, whose type of insurance is “non-distribution professional engineer” as shown in the separate sheet.

(2) Under the insurance contract of this case, the Plaintiff shall pay 40,000,000 won per day of hospitalization as the diagnosis cost for cerebrovascular disease, 100,000 won per day of hospitalization as the daily allowance for cerebrovascular disease, and 20,000 won per day of hospitalization as the daily allowance for cerebrscular disease.

(3) Meanwhile, according to the terms and conditions of the instant insurance contract, “cerebrovascular disease” should be determined by a person with a doctor’s license (excluding dentists), who is classified as a cerebrovascular disease under the 4th Korean Standard Medical Disease Classification. They should be conducted based on brain computer-oriented stratographing, nuclear self-defluence (MRI), cerebrovascularic typhical typhical typhical typhical typhical typhical typhical typhical typhicals (PET), ES electronic typhical typhical typhical typhical typhicals (SPEC), and brain cephical

(See attached Table 5 of the above Special Terms and Conditions). Consumption of cerebral cerebral cerebral typysys

1. Spande part thereof;

2. Brain;

3. Other blood transfusions from a noncommercial head.

4. Color;

5. Severe dys not indicated by blood or light flaposis;

6. Scrapping and fluoring of bovine spongiform encephalopathy which does not cause any bovine spongiform encephalopathy;

7. Waste color and fluoring of an anti-cerebrovascular which does not cause any bovine spongiform encephalopathy;

8. Other cerebrovascular diseases.

9.Ethic 10 Ethic mathic mathic mathic mathic mathic mathic 160 I61 I62 I63 I64 I65 I66 I67 I68 I69

B. The Defendant’s claim and refusal to pay the insurance proceeds (1) returned to B on May 19, 2014 to two copies, and the Defendant was diagnosed at the brain MTRA test conducted by the same hospital on May 28, 2014, and was hospitalized in B hospital for one week at that time.

(2) it.